Elizabeth L.R. Donley
Stemina Biomarker Discovery (United States)(US)
Publications by Year
Research Areas
Pluripotent Stem Cells Research, Autism Spectrum Disorder Research, 3D Printing in Biomedical Research, Effects and risks of endocrine disrupting chemicals, Genetics and Neurodevelopmental Disorders
Most-Cited Works
- → Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics(2010)185 cited
- → Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children(2014)151 cited
- → Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder(2018)137 cited
- → Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics(2011)104 cited
- → Establishment and Assessment of a New Human Embryonic Stem Cell‐Based Biomarker Assay for Developmental Toxicity Screening(2013)96 cited
- → A Metabolomics Approach to Screening for Autism Risk in the Children's Autism Metabolome Project(2020)52 cited
- → A human induced pluripotent stem cell-based in vitro assay predicts developmental toxicity through a retinoic acid receptor-mediated pathway for a series of related retinoid analogues(2017)36 cited
- → A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential(2020)34 cited
- → Quantitative in vitro to in vivo extrapolation for developmental toxicity potency of valproic acid analogues(2022)23 cited
- → microRNAs signatures as potential biomarkers of structural cardiotoxicity in human-induced pluripotent stem-cell derived cardiomyocytes(2022)15 cited